Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

United States Idiopathic Pulmonary Fibrosis Market and Competitive Landscape Highlights 2010-2020 - Research and Markets

Research and Markets
Posted on: 05 Oct 16

Research and Markets has announced the addition of the "US Idiopathic Pulmonary Fibrosis Market and Competitive Landscape Highlights - 2016" drug pipelines to their offering.

The report "US Idiopathic Pulmonary Fibrosis Market and Competitive Landscape Highlights - 2016" provides comprehensive insights into Idiopathic Pulmonary Fibrosis pipeline products, Idiopathic Pulmonary Fibrosis epidemiology, Idiopathic Pulmonary Fibrosis market valuations and forecast, Idiopathic Pulmonary Fibrosis products sales and competitive landscape in the US.

The research is classified into nine sections - Idiopathic Pulmonary Fibrosis overview including etiology, pathophysiology, and diagnosis, Idiopathic Pulmonary Fibrosis treatment options, Idiopathic Pulmonary Fibrosis pipeline products, Idiopathic Pulmonary Fibrosis market analysis comprising of Idiopathic Pulmonary Fibrosis epidemiology, key products marketed for Idiopathic Pulmonary Fibrosis, market valuations and forecast, products sales and market shares.

Research Scope:

  • Idiopathic Pulmonary Fibrosis Pipeline: Find out the products in clinical trials for the treatment of Idiopathic Pulmonary Fibrosis by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
  • Idiopathic Pulmonary Fibrosis Epidemiology: Find out the number of patients diagnosed (prevalence) with Idiopathic Pulmonary Fibrosis in the US
  • Idiopathic Pulmonary Fibrosis Products: Identify key products marketed and prescribed for Idiopathic Pulmonary Fibrosis in the US, including trade name, molecule name, and company
  • Idiopathic Pulmonary Fibrosis Product Sales: Find out the sales revenues of Idiopathic Pulmonary Fibrosis products, both branded and generics, in the US
  • Idiopathic Pulmonary Fibrosis Market Valuations: Find out the market size for Idiopathic Pulmonary Fibrosis products in 2015 in the US. Find out how the market advanced from 2010 and forecast to 2020
  • Idiopathic Pulmonary Fibrosis Products Market Share: Find out the market shares for key Idiopathic Pulmonary Fibrosis products in the US

Key Topics Covered:

  1. Disease Overview
  2. Idiopathic Pulmonary Fibrosis Treatments
  3. Idiopathic Pulmonary Fibrosis Pipeline
  4. US Idiopathic Pulmonary Fibrosis Epidemiology
  5. Marketed Drugs for Idiopathic Pulmonary Fibrosis in US
  6. US Idiopathic Pulmonary Fibrosis Market Size
  7. US Idiopathic Pulmonary Fibrosis Products Sales
  8. US Idiopathic Pulmonary Fibrosis Market Competitive Landscape
  9. US Idiopathic Pulmonary Fibrosis Market Forecast

For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/zzhx7c/us_idiopathic

View source version on businesswire.com: http://www.businesswire.com/news/home/20161005005783/en/

Business Wire
www.businesswire.com

Last updated on: 05/10/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.